Teva Pharmaceuticals USA, Barr Laboratories and several other generic drug manufacturers have been sued by Sanofi-Aventis SA for allegedly infringing on two of the drug giant's U.S. patents for Uroxatral, for treating prostate gland enlargement. None of the accused companies commented on the two complaints.

Full Story:

Related Summaries